yourstate.us
Utah Code § 31A-22-641

Cancer treatment parity

Utah · Utah Code Title 31A — Insurance Code · Status: effective

Get this as JSONEmbed this
Cite this
Citation
Utah Code § 31A-22-641, Cancer treatment parity, Utah, version 1 as recorded 2026-10-03, yourstate.us, https://yourstate.us/provision/2333760
Permanent ID
ys:prov:2333760@1
SHA-256
1a21a8057151ea0ed0913c35134f82ce47cf4368e1e360a9e612ddab03622e84

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(1) For purposes of this section: (a) "Cost sharing" means the enrollee's maximum out-of-pocket costs as defined by the health benefit plan. (b) "Health insurer" is as defined in Subsection 31A-22-634(1). (c) "Intravenously administered chemotherapy" means a physician-prescribed cancer treatment that is used to kill or slow the growth of cancer cells, that is administered through injection directly into the patient's circulatory system by a physician, physician assistant, nurse practitioner, nurse, or other medical personnel under the supervision of a physician, and in a hospital, medical office, or other clinical setting. (d) "Oral chemotherapy" means a United States Food and Drug Administration-approved, physician-prescribed cancer treatment that is used to kill or slow the growth of cancer cells, that is taken orally in the form of a tablet or capsule, and may be administered in a hospital, medical office, or other clinical setting or may be delivered to the patient for self-administration under the direction or supervision of a physician outside of a hospital, medical office, or other clinical setting. (2) This section applies to health benefit plans renewed or entered into on or after October 1, 2013. (3) A health benefit plan that covers prescribed oral chemotherapy and intravenously administered chemotherapy shall: (a) except as provided in Subsection (3)(b), ensure that the cost sharing applied to the covered oral chemotherapy is no more restrictive than the cost sharing applied to the covered intravenously administered chemotherapy; or (b) if the cost sharing for oral chemotherapy is more restrictive than the cost sharing for intravenous chemotherapy, the health benefit plan may not apply cost sharing for the oral chemotherapy that exceeds $300 per filled prescription. (4) (a) A health insurer shall not increase the cost sharing for intravenously administered chemotherapy for the purpose of achieving compliance with this section. (b) The commissioner may adopt administrative rules in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to enforce the provisions of this section.